What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q2 2023?

143 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 98,652,577
Share change: -9,185,587
Total reported value: $114,435,495
Put/Call ratio: 308%
Price per share: $1.16
Number of holders: 143
Value change: -$11,706,623
Number of buys: 55
Number of sells: 77

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRANKLIN RESOURCES INC	13F	Company	6.5%	11,870,096	$17,923,844	—	31 Mar 2023	13F
Rubric Capital Management LP	13F	Company	6.4%	11,750,000	$17,742,500	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5.1%	9,401,084	$14,195,634	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	4.6%	8,430,618	$12,730,233	—	31 Mar 2023	13F
BAKER BROS. ADVISORS LP	13F	Company	4.5%	8,131,678	$12,278,834	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	3.9%	7,086,523	$10,701,000	—	31 Mar 2023	13F
Velan Capital Investment Management LP	3/4/5 13F	Other* · Company	2.5% from 13F	4,500,000	$9,675,000	—	30 Jan 2023	3/4/5 13F
GREAT POINT PARTNERS LLC	13F	Company	3.2%	5,817,368	$8,784,226	—	31 Mar 2023	13F
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	2.2%	3,970,286	$5,995,132	—	31 Mar 2023	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.8%	3,337,314	$5,039,344	—	31 Mar 2023	13F
Deep Track Capital, LP	13F	Company	1.8%	3,234,722	$4,884,430	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	1.4%	2,555,993	$3,859,978	—	31 Mar 2023	13F
Clearline Capital LP	13F	Company	1.1%	2,089,292	$3,154,831	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	1,974,954	$2,982,180	—	31 Mar 2023	13F
Tejara Capital Ltd	13F	Company	0.91%	1,667,519	$2,517,954	—	31 Mar 2023	13F
Barry D. Quart	3/4/5	Chief Executive Officer, Director	— mixed-class rows	1,142,796 mixed-class rows	$2,142,511	—	18 Jan 2023	3/4/5
Orchard Capital Management, LLC	13F	Company	0.76%	1,391,080	$2,100,531	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.62%	1,140,836	$1,723,000	—	31 Mar 2023	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.59%	1,071,124	$1,617,397	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.57%	1,049,799	$1,585,196	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.54%	983,762	$1,485,481	—	31 Mar 2023	13F
Kevin Kotler	3/4/5	Director	— class O/S missing	577,879	$1,242,440	—	22 Feb 2023	3/4/5
ORBIMED ADVISORS LLC	13F	Company	0.44%	802,700	$1,212,077	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.4%	731,126	$1,104,000	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.39%	721,031	$1,089,000	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.39%	721,082	$1,088,834	—	31 Mar 2023	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.39%	705,677	$1,065,572	—	31 Mar 2023	13F
Pekin Hardy Strauss, Inc.	13F	Company	0.31%	571,705	$863,275	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.31%	569,212	$859,510	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.31%	565,788	$854,000	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.3%	550,000	$830,500	—	31 Mar 2023	13F
HRT FINANCIAL LP	13F	Company	0.3%	547,365	$826,000	—	31 Mar 2023	13F
NEXPOINT ASSET MANAGEMENT, L.P.	13F	Company	0.27%	499,131	$753,688	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.25%	455,997	$688,555	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	404,309	$610,506	—	31 Mar 2023	13F
Fisher Asset Management, LLC	13F	Company	0.22%	403,189	$608,815	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.19%	352,774	$532,688	—	31 Mar 2023	13F
CM Management, LLC	13F	Company	0.19%	350,000	$529,000	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.18%	335,229	$506,196	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.18%	328,675	$496,299	—	31 Mar 2023	13F
JACOB ASSET MANAGEMENT OF NEW YORK LLC	13F	Company	0.18%	326,657	$493,252	—	31 Mar 2023	13F
Congress Park Capital LLC	13F	Company	0.18%	320,660	$484,197	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.17%	312,286	$471,552	—	31 Mar 2023	13F
Simplify Asset Management Inc.	13F	Company	0.17%	306,590	$462,951	—	31 Mar 2023	13F
KBC Group NV	13F	Company	0.16%	289,269	$437,000	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.15%	279,000	$421,290	—	31 Mar 2023	13F
AXA S.A.	13F	Company	0.15%	265,000	$400,150	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.14%	256,600	$387,466	—	31 Mar 2023	13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC	13F	Company	0.14%	250,416	$378,128	—	31 Mar 2023	13F
XTX Topco Ltd	13F	Company	0.13%	235,974	$356,321	—	31 Mar 2023	13F

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2023

As of 30 Jun 2023, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 98,652,577 shares. The largest 10 holders included Rubric Capital Management LP, BlackRock Inc., VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, GREAT POINT PARTNERS LLC, Velan Capital Investment Management LP, PALISADE CAPITAL MANAGEMENT, LP, and Clearline Capital LP. This page lists 143 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

153

Q2 2023 holders

143

Holder diff

-10

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.